Mallinckrodt Archives

Press ESC key to close search

U.S. Bankruptcy Court Confirms Mallinckrodt’s Plan of Reorganization

The U.S. Bankruptcy Court for the District of Delaware confirmed Mallinckrodt’s plan of reorganization, paving the way for the company to begin the next stage in its reorganization process.

AlixPartners Advises Mallinckrodt on Chapter 11 Proceedings, Restructuring

AlixPartners is serving as restructuring advisor to Mallinckrodt, which initiated Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware to modify its capital structure, including restructuring portions of its debt.

October 12, 2020 AlixPartners | Mallinckrodt | Mark Trudeau Ellie Delany

Deutsche Supports Mallinckrodt/Sun Acquisition Merger

Mallinckrodt entered into an agreement to merge Sun Acquisition and Sucampo Pharmaceuticals. Deutsche Bank agented a $900 million revolving credit facility to support the transaction.

January 15, 2018 Mallinckrodt | Sucampo Pharmaceuticals | Sun Acquisition ABF Journal

Deutsche Bank Provides $500MM Term Loan for Mallinckrodt Sucampo Purchase

Mallinckrodt agreed to acquire biopharmaceutical company Sucampo Pharmaceuticals, including its commercial and development assets, for $1.2 billion. The transaction was approved by the boards of directors of both companies.

December 27, 2017 Deutsche Bank | Deutsche Bank Securities | Mallinckrodt | Sucampo Pharmaceuticals Amanda Koprowski

<img width="200" src="https://www.abfjournal.com/wp-content/uploads/2020/02/abfj-logo-web-header1-blue.png" alt="ABFJournal" />

Tag Archives: Mallinckrodt

U.S. Bankruptcy Court Confirms Mallinckrodt’s Plan of Reorganization

AlixPartners Advises Mallinckrodt on Chapter 11 Proceedings, Restructuring

Deutsche Supports Mallinckrodt/Sun Acquisition Merger

Deutsche Bank Provides $500MM Term Loan for Mallinckrodt Sucampo Purchase